142 related articles for article (PubMed ID: 25450579)
1. PINK1 signalling in cancer biology.
O'Flanagan CH; O'Neill C
Biochim Biophys Acta; 2014 Dec; 1846(2):590-8. PubMed ID: 25450579
[TBL] [Abstract][Full Text] [Related]
2. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
3. PINK1 overexpression protects against C2-ceramide-induced CAD cell death through the PI3K/AKT pathway.
Sánchez-Mora RM; Arboleda H; Arboleda G
J Mol Neurosci; 2012 Jul; 47(3):582-94. PubMed ID: 22212487
[TBL] [Abstract][Full Text] [Related]
4. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
5. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
[TBL] [Abstract][Full Text] [Related]
6. Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1).
Mills RD; Sim CH; Mok SS; Mulhern TD; Culvenor JG; Cheng HC
J Neurochem; 2008 Apr; 105(1):18-33. PubMed ID: 18221368
[TBL] [Abstract][Full Text] [Related]
7. The Parkinson's disease gene
Furlong RM; Lindsay A; Anderson KE; Hawkins PT; Sullivan AM; O'Neill C
J Cell Sci; 2019 Oct; 132(20):. PubMed ID: 31540955
[TBL] [Abstract][Full Text] [Related]
8. AKT signaling in physiology and disease.
Vasudevan KM; Garraway LA
Curr Top Microbiol Immunol; 2010; 347():105-33. PubMed ID: 20549472
[TBL] [Abstract][Full Text] [Related]
9. [PI3K-AKT-mTOR pathway inhibitors].
Cortot A; Armand JP; Soria JC
Bull Cancer; 2006 Jan; 93(1):19-26. PubMed ID: 16455502
[TBL] [Abstract][Full Text] [Related]
10. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
Sim CH; Lio DS; Mok SS; Masters CL; Hill AF; Culvenor JG; Cheng HC
Hum Mol Genet; 2006 Nov; 15(21):3251-62. PubMed ID: 17000703
[TBL] [Abstract][Full Text] [Related]
11. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
12. Dolastatin, along with Celecoxib, stimulates apoptosis by a mechanism involving oxidative stress, membrane potential change and PI3-K/AKT pathway down regulation.
Piplani H; Rana C; Vaish V; Vaiphei K; Sanyal SN
Biochim Biophys Acta; 2013 Nov; 1830(11):5142-56. PubMed ID: 23872169
[TBL] [Abstract][Full Text] [Related]
13. PINK1 signaling in mitochondrial homeostasis and in aging (Review).
Kitagishi Y; Nakano N; Ogino M; Ichimura M; Minami A; Matsuda S
Int J Mol Med; 2017 Jan; 39(1):3-8. PubMed ID: 27959386
[TBL] [Abstract][Full Text] [Related]
14. PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons.
Wang HL; Chou AH; Wu AS; Chen SY; Weng YH; Kao YC; Yeh TH; Chu PJ; Lu CS
Biochim Biophys Acta; 2011 Jun; 1812(6):674-84. PubMed ID: 21421046
[TBL] [Abstract][Full Text] [Related]
15. NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions.
Murata H; Takamatsu H; Liu S; Kataoka K; Huh NH; Sakaguchi M
PLoS One; 2015; 10(11):e0142438. PubMed ID: 26555609
[TBL] [Abstract][Full Text] [Related]
16. Biochemical properties of the kinase PINK1 as sensor protein for mitochondrial damage signalling.
Rüb C; Schröder N; Voos W
Biochem Soc Trans; 2015 Apr; 43(2):287-91. PubMed ID: 25849931
[TBL] [Abstract][Full Text] [Related]
17. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.
Zhang H; Cicchetti G; Onda H; Koon HB; Asrican K; Bajraszewski N; Vazquez F; Carpenter CL; Kwiatkowski DJ
J Clin Invest; 2003 Oct; 112(8):1223-33. PubMed ID: 14561707
[TBL] [Abstract][Full Text] [Related]
18. [Molecular genetics of PINK1].
Funayama M; Hattori N
Brain Nerve; 2007 Aug; 59(8):831-8. PubMed ID: 17713119
[TBL] [Abstract][Full Text] [Related]
19. [Advances on PI3K/Akt/mTOR signalling pathway in malignancies].
Yu BH; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2005 Oct; 34(10):674-6. PubMed ID: 16536284
[No Abstract] [Full Text] [Related]
20. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
